BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2554871)

  • 1. Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility?
    Brodde OE; Zerkowski HR
    Basic Res Cardiol; 1989; 84 Suppl 1():135-44. PubMed ID: 2554871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies.
    Motomura S; Reinhard-Zerkowski H; Daul A; Brodde OE
    Am Heart J; 1990 Mar; 119(3 Pt 1):608-19. PubMed ID: 1968697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
    Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease.
    Brodde OE; Zerkowski HR; Doetsch N; Motomura S; Khamssi M; Michel MC
    J Am Coll Cardiol; 1989 Aug; 14(2):323-31. PubMed ID: 2569001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
    Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors.
    Brodde OE; Zerkowski HR; Borst HG; Maier W; Michel MC
    Eur Heart J; 1989 Jun; 10 Suppl B():38-44. PubMed ID: 2553410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of beta-adrenoceptor subtypes in cardiac contractility].
    Yanagisawa T
    Nihon Yakurigaku Zasshi; 1992 Sep; 100(3):193-204. PubMed ID: 1356896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional importance of beta 1 and beta 2 adrenoceptors in the human heart.
    Brodde OE
    Am J Cardiol; 1988 Aug; 62(5):24C-29C. PubMed ID: 2900601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists?
    Brodde OE
    Eur Heart J; 1991 Dec; 12 Suppl F():54-62. PubMed ID: 1687117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta- and alpha-adrenoceptor-agonists and -antagonists in chronic heart failure.
    Brodde OE
    Basic Res Cardiol; 1990; 85 Suppl 1():57-66. PubMed ID: 1965405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated beta-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalization.
    Pitschner HF; Droege A; Mitze M; Schlepper M; Brodde OE
    Basic Res Cardiol; 1993; 88(2):179-91. PubMed ID: 8389122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo studies on the function of cardiac beta-adrenoceptors in man.
    McDevitt DG
    Eur Heart J; 1989 Jun; 10 Suppl B():22-8. PubMed ID: 2553409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human cardiac function through 4 beta-adrenoceptor populations.
    Kaumann AJ; Molenaar P
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):667-81. PubMed ID: 9205950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
    Schumacher C; Becker H; Conrads R; Schotten U; Pott S; Kellinghaus M; Sigmund M; Schöndube F; Preusse C; Schulte HD
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):398-407. PubMed ID: 7630430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.